DeGolyer Donald W 4
4 · Emergent BioSolutions Inc. · Filed Nov 12, 2025
Insider Transaction Report
Form 4
DeGolyer Donald W
Director
Transactions
- Sale
Common Stock
2025-11-10$10.54/sh−17,801$187,623→ 119,858 total
Footnotes (2)
- [F1]Represents the number of shares sold by the Reporting Person. Shares were sold pursuant to a Rule 10b5-1 trading plan, dated August 11, 2025, for the purpose of satisfying tax obligations relating to the vesting of RSUs on October 2, 2025.
- [F2]For reporting purposes, sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $10.33 - $10.79. The Company maintains a record of the transactions and copies will be provided upon request.